BCG Vaccination Scar Formation in Children Under Five Years :Factors Affecting Its Formation and Subsequent Adverse Effects .
NCT03548233 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-03-16
Summary
Study of BCG Vaccination scars of under five years old children . Estimation of the frequency of children without BCG scar after BCG vaccine . Evaluation of factors which may affect scar formation . Tuberculin skin test response in children without BCG scar . Frequency of vaccine adverse effects as injection-site abscess, lymphadenitis, severe local reaction, and disseminated BCG infection.
Conditions
- BCG Vaccination Reaction
Interventions
- BIOLOGICAL
-
bcg vaccine
live attenuated vaccine
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
mohamed ghazaly, professor · assiut universitypediatric hospital
-
mustafa embaby, assistprof · assiut universitypediatric hospital
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Months
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2021-12-01
- Completion
- 2021-12-01
More Related Trials
-
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
NCT00242047 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
NCT00480714 ·Status: COMPLETED ·Phase: NA
-
Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?
NCT00146302 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults.
NCT04507126 ·Status: COMPLETED ·Phase: PHASE2
-
Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections
NCT04884308 ·Status: COMPLETED ·Phase: PHASE2
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial
NCT02504203 ·Status: TERMINATED ·Phase: PHASE4
-
BCG Revaccination in Children and Adolescents
NCT05330884 ·Status: SUSPENDED ·Phase: PHASE3
-
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
NCT05387655 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
NCT02444611 ·Status: COMPLETED ·Phase: NA
-
A Study of the Interaction Between BCG And MenC Immunisation: BAM
NCT02002156 ·Status: COMPLETED ·Phase: PHASE4
-
Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction
NCT01906853 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of BCG Vaccine for Intradermal Injection
NCT04563273 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination
NCT00653627 ·Status: COMPLETED ·Phase: PHASE1
-
Low Birth Weight Follow-up
NCT03020147 ·Status: COMPLETED
-
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
NCT01420705 ·Status: COMPLETED
-
A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)
NCT00440544 ·Status: TERMINATED ·Phase: PHASE1
-
Using BCG Vaccine to Understand Tuberculosis Infection
NCT05820594 ·Status: UNKNOWN ·Phase: NA
-
Trial of Two Strains of BCG
NCT02447536 ·Status: COMPLETED ·Phase: PHASE4
-
Non-specific Effects of BCG in Under-five Children
NCT05471167 ·Status: UNKNOWN
-
Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates
NCT03536117 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe
NCT01742364 ·Status: COMPLETED ·Phase: NA
-
BCG Vaccination Delivered Intradermally, Orally and by Combined Routes
NCT00396370 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
NCT02378207 ·Status: COMPLETED ·Phase: PHASE1
-
A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A
NCT01194180 ·Status: COMPLETED ·Phase: PHASE1